Steven Sell - 14 Sep 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
CEO & President, Director
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Sep 2021
Net transactions value
-$2,448,000
Form type
4
Filing time
15 Sep 2021, 17:21:10 UTC
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $450,000 +100,000 $4.50* 100,000 14 Sep 2021 Direct
transaction AGL Common Stock Sale $2,898,000 -100,000 -100% $28.98 0 14 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -100,000 -10% $0.000000 900,000 14 Sep 2021 Common Stock 100,000 $4.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on May 22, 2020, and fully vested on April 19, 2021.